Table 1.
The expression and clinical characteristics of HNF1A-AS1 in human cancers
| Disease type | Expression | Clinical characteristics | Refs |
|---|---|---|---|
| gastric cancer | upregulated | lymph node metastasis | [26-28] |
| downregulated | tumor size, levels of serum carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), and RRM1 expression | [24] | |
| gastric cancer | upregulated | / | [28] |
| liver cancer | upregulated | tumor size, tumor stage, multiple lesions, and poor differentiation | [29-31] |
| downregulated | / | [23] | |
| glioma | upregulated | overall survival | [32-34] |
| lung cancer | upregulated | overall survival, pathological stage, TNM stage, tumor size, and lymph node metastasis | [35-39] |
| colorectal cancer | upregulated | tumor size, TNM stage, lymph nodes metastasis, distant metastasis, overall survival, disease-free survival, and vascular invasion | [40-44] |
| colorectal cancer | upregulated | / | [88] |
| breast cancer | upregulated | overall survival | [45-47] |
| bladder cancer | upregulated | histological grade, TNM stage, lymph nodes metastasis, and overall survival | [48-50] |
| osteosarcoma | upregulated | clinical stage, distance metastasis, chemotherapy resistance, and poor overall survival | [51-53] |
| cervical cancer | upregulated | / | [56,57] |
| esophageal adenocarcinoma | upregulated | / | [25] |
| hemangioma | upregulated | [54] | |
| oral squamous cell carcinoma | upregulated | nodal invasion, tumor stage, and tissue differentiation | [55] |
| laryngeal squamous cell carcinoma | downregulated | / | [22] |
| gastroenteropancreatic neuroendocrine neoplasms | downregulated | / | [58] |